Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_assertion type Assertion NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_head.
- NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_assertion description "[Here we report that high-grade serous ovarian cancer is characterized by TP53 mutations in almost all tumours (96%); low prevalence but statistically recurrent somatic mutations in nine further genes including NF1, BRCA1, BRCA2, RB1 and CDK12; 113 significant focal DNA copy number aberrations; and promoter methylation events involving 168 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_provenance.
- NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_assertion evidence source_evidence_literature NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_provenance.
- NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_assertion SIO_000772 21720365 NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_provenance.
- NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_assertion wasDerivedFrom befree-2016 NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_provenance.
- NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_assertion wasGeneratedBy ECO_0000203 NP906294.RAJ1W1AxQ-0RX-kVEnuwa0-3ev0gcATRXScBA6SGu-0H8130_provenance.